Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeut... Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally. 詳細を表示
HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS PR Newswire SAN DIEGO, Oct. 31, 2024 Total Revenue Increased 34% YOY to $290 million and Royalty Revenue Increased 36% YOY to...
HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE PR Newswire SAN DIEGO, Oct. 24, 2024 Company Projects No Impact on U.S. or European Royalty Revenues from DARZALEX...
Halozyme to Report Third Quarter 2024 Financial and Operating Results PR Newswire SAN DIEGO, Oct. 23, 2024 SAN DIEGO, Oct. 23, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO...
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use Commercial Drone market expected to grow at 23.7 CAGR (Compound Annual Growth Rate) through 2030 Miami, FL...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.94 | -1.5524360033 | 60.55 | 62.128 | 58.005 | 1329816 | 60.40161828 | CS |
4 | 6.18 | 11.5665356541 | 53.43 | 62.128 | 48.84 | 1290182 | 55.24742388 | CS |
12 | -1.86 | -3.02586627623 | 61.47 | 65.5327 | 48.84 | 1355420 | 57.38786579 | CS |
26 | 16.12 | 37.0659921821 | 43.49 | 65.5327 | 42.05 | 1333872 | 54.47250734 | CS |
52 | 22.49 | 60.5872844828 | 37.12 | 65.5327 | 33.15 | 1251622 | 46.91659363 | CS |
156 | 20.44 | 52.1827929538 | 39.17 | 65.5327 | 29.85 | 1191976 | 43.55976366 | CS |
260 | 43.61 | 272.5625 | 16 | 65.5327 | 12.71 | 1246199 | 38.38092285 | CS |
銘柄コード | 株価 | 出来高 |
---|---|---|
NMHINatures Miracle Holding Inc | US$ 0.1456 (69.89%) | 6.03M |
MVSTMicrovast Holdings Inc | US$ 0.3391 (87.66%) | 1.35M |
TSLLDirexion Daily TSLA Bull 2X Trust ETF | US$ 20.39 (3.45%) | 819.16k |
TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 4.34 (-3.13%) | 397.82k |
TSLQInvestment Managers Series Trust II Tradr 2X Short TSLA Daily | US$ 7.92 (-3.30%) | 386k |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約